Antisense Therapeutics Limited

Antisense Therapeutics Limited is an Australian publicly listed biopharmaceutical drug discovery and development company with the mission to create, develop, and commercialize novel antisense therapeutic drugs for multiple candidate indications, including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly.